NO179551C - Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser

Info

Publication number
NO179551C
NO179551C NO884729A NO884729A NO179551C NO 179551 C NO179551 C NO 179551C NO 884729 A NO884729 A NO 884729A NO 884729 A NO884729 A NO 884729A NO 179551 C NO179551 C NO 179551C
Authority
NO
Norway
Prior art keywords
alkyl
halogen
hydrogen
compounds
substituted
Prior art date
Application number
NO884729A
Other languages
English (en)
Other versions
NO179551B (no
NO884729D0 (no
NO884729L (no
Inventor
Tage Honore
Poul Jacobsen
Flemming Elmelund Nielsen
Lars Naerum
Original Assignee
Novo Nordisk As
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK586287A external-priority patent/DK586287D0/da
Priority claimed from DK142288A external-priority patent/DK142288D0/da
Application filed by Novo Nordisk As, Ferrosan As filed Critical Novo Nordisk As
Publication of NO884729D0 publication Critical patent/NO884729D0/no
Publication of NO884729L publication Critical patent/NO884729L/no
Publication of NO179551B publication Critical patent/NO179551B/no
Priority to NO963412A priority Critical patent/NO307252B1/no
Publication of NO179551C publication Critical patent/NO179551C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
NO884729A 1987-11-10 1988-10-24 Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser NO179551C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO963412A NO307252B1 (no) 1987-11-10 1996-08-15 Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK586287A DK586287D0 (da) 1987-11-10 1987-11-10 Quinoxalinforbindelser, deres fremstilling og anvendelse
DK142288A DK142288D0 (da) 1988-03-16 1988-03-16 Quinoxalinforbindelser, deres fremstilling og anvendelse

Publications (4)

Publication Number Publication Date
NO884729D0 NO884729D0 (no) 1988-10-24
NO884729L NO884729L (no) 1989-05-11
NO179551B NO179551B (no) 1996-07-22
NO179551C true NO179551C (no) 1996-10-30

Family

ID=26065733

Family Applications (2)

Application Number Title Priority Date Filing Date
NO884729A NO179551C (no) 1987-11-10 1988-10-24 Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
NO963412A NO307252B1 (no) 1987-11-10 1996-08-15 Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO963412A NO307252B1 (no) 1987-11-10 1996-08-15 Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser

Country Status (16)

Country Link
US (2) US4948794A (no)
EP (1) EP0315959B1 (no)
JP (1) JP2721520B2 (no)
KR (1) KR970011279B1 (no)
AT (1) ATE102192T1 (no)
AU (1) AU618766B2 (no)
CA (1) CA1321587C (no)
DE (1) DE3888093T2 (no)
ES (1) ES2061606T3 (no)
FI (1) FI100181B (no)
IE (1) IE64320B1 (no)
IL (1) IL88155A0 (no)
NO (2) NO179551C (no)
NZ (1) NZ226916A (no)
PH (1) PH25103A (no)
PT (1) PT88964B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
AU656154B2 (en) * 1990-11-06 1995-01-27 Astellas Pharma Inc. Fused pyrazine derivative
PT99864B (pt) 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
US5196421A (en) * 1991-06-05 1993-03-23 Eli Lilly And Company Excitatory amino acid receptor antagonists in methods for the use thereof
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
DK177191D0 (da) * 1991-10-23 1991-10-23 Novo Nordisk As Heterocyclic compounds and their preparation and use
US6057304A (en) * 1992-10-26 2000-05-02 Schering Aktiengesellschaft Quinoxaline-phosphonic acid derivatives
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
PT647137E (pt) * 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
FR2696466B1 (fr) * 1992-10-02 1994-11-25 Rhone Poulenc Rorer Sa Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.
DK12293D0 (da) * 1993-02-02 1993-02-02 Novo Nordisk As Heterocykliske forbindelser og deres fremstilling og anvendelse
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
AU688459B2 (en) * 1994-04-08 1998-03-12 Shionogi & Co., Ltd. Oxopyridinylquinoxaline derivative
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19545251A1 (de) * 1995-11-24 1997-05-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
ID21927A (id) * 1996-10-24 1999-08-12 Novartis Ag Asam aminoalkanafosfonat tersubstitusi
WO1998035948A1 (en) * 1997-02-18 1998-08-20 American Home Products Corporation 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
JP4707261B2 (ja) * 2001-05-15 2011-06-22 日本エンバイロケミカルズ株式会社 キノキサリン系化合物および工業用殺菌組成物
JP2007500245A (ja) * 2003-06-10 2007-01-11 スミスクライン ビーチャム コーポレーション 化合物
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
US8673915B2 (en) 2010-07-29 2014-03-18 Nippon Chemiphar Co., Ltd. P 2×4 receptor antagonist
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions
US10890033B1 (en) 2017-12-10 2021-01-12 Watson, Incorporated Kelly bar with locking feature, related system and method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431111A (en) * 1963-06-10 1969-03-04 Eastman Kodak Co Cyanine dyes
US3992378A (en) * 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
EP0030795A3 (en) * 1979-12-06 1981-09-09 Imperial Chemical Industries Plc Quinoxaline derivatives, processes therefor, pharmaceutical compositions, and benzene derivatives
DE3165028D1 (de) * 1980-05-09 1984-08-30 Usv Pharma Corp Triazaloquinoxalin-1,4-diones
US4659713A (en) * 1984-10-01 1987-04-21 International Minerals & Chemical Corp. Quinoxalinedione compounds useful for controlling coccidiosis
US4812458A (en) * 1986-09-16 1989-03-14 A/S Ferrosan 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser

Also Published As

Publication number Publication date
DE3888093T2 (de) 1994-06-09
NO179551B (no) 1996-07-22
NO884729D0 (no) 1988-10-24
PH25103A (en) 1991-02-19
EP0315959A3 (en) 1989-12-27
FI885151A (fi) 1989-05-11
IE883209L (en) 1989-05-10
KR970011279B1 (ko) 1997-07-09
EP0315959B1 (en) 1994-03-02
US5026704A (en) 1991-06-25
NO884729L (no) 1989-05-11
NO307252B1 (no) 2000-03-06
FI885151A0 (fi) 1988-11-09
EP0315959A2 (en) 1989-05-17
DE3888093D1 (de) 1994-04-07
IE64320B1 (en) 1995-07-26
AU2494988A (en) 1989-05-11
FI100181B (fi) 1997-10-15
ES2061606T3 (es) 1994-12-16
KR890008113A (ko) 1989-07-08
NZ226916A (en) 1991-01-29
JP2721520B2 (ja) 1998-03-04
US4948794A (en) 1990-08-14
PT88964B (pt) 1993-02-26
PT88964A (pt) 1988-12-01
ATE102192T1 (de) 1994-03-15
CA1321587C (en) 1993-08-24
NO963412L (no) 1989-05-11
JPH01153680A (ja) 1989-06-15
IL88155A0 (en) 1989-06-30
AU618766B2 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
NO963412L (no) Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
NO178662C (no) Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoksalinforbindelser
NO178661C (no) Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoksalinforbindelser
FI92582B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi
ATE88344T1 (de) Zur behandlung von neurodegenerativen erkrankungen verwendbare kynurensaeurederivate.
NO173499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinoxalinforbindelser
DK620688A (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
FI862062A0 (fi) Foerfarande foer framstaellning av oxadiazolyl-imidazobensodiazepinfoereningar.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2003